SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 146 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2017. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $560,000 | +38.3% | 251,341 | +79.9% | 0.04% | +21.6% |
| Q3 2017 | $405,000 | -81.1% | 139,704 | -71.0% | 0.04% | -81.8% |
| Q2 2017 | $2,147,000 | -7.9% | 482,444 | -3.6% | 0.20% | -9.0% |
| Q1 2017 | $2,331,000 | +71.3% | 500,298 | +123.9% | 0.22% | +36.0% |
| Q4 2016 | $1,361,000 | +79.1% | 223,436 | +62.1% | 0.16% | +105.0% |
| Q3 2016 | $760,000 | +2135.3% | 137,870 | +1048.9% | 0.08% | +1500.0% |
| Q1 2016 | $34,000 | -80.6% | 12,000 | -61.2% | 0.01% | -81.5% |
| Q4 2015 | $175,000 | +218.2% | 30,900 | +197.1% | 0.03% | +237.5% |
| Q3 2015 | $55,000 | -75.4% | 10,400 | -61.5% | 0.01% | -74.2% |
| Q2 2015 | $224,000 | +433.3% | 27,000 | +80.0% | 0.03% | +416.7% |
| Q3 2014 | $42,000 | -31.1% | 15,000 | 0.0% | 0.01% | -25.0% |
| Q2 2014 | $61,000 | -80.3% | 15,000 | -74.3% | 0.01% | -80.5% |
| Q1 2014 | $310,000 | +189.7% | 58,400 | +207.4% | 0.04% | +127.8% |
| Q4 2013 | $107,000 | +55.1% | 19,000 | +26.7% | 0.02% | +63.6% |
| Q3 2013 | $69,000 | +6.2% | 15,000 | 0.0% | 0.01% | -21.4% |
| Q2 2013 | $65,000 | – | 15,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,273,509 | $9,493,000 | 1.85% |
| Trellus Management Company, LLC | 362,500 | $1,051,000 | 1.44% |
| Paulson & Co. | 24,062,368 | $69,781,000 | 1.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 971,922 | $2,799,000 | 1.09% |
| Asymmetry Capital Management, L.P. | 271,102 | $786,000 | 0.91% |
| Cheyne Capital Management (UK) LLP | 651,500 | $1,880,000 | 0.68% |
| Hikari Power Ltd | 1,500,000 | $4,350,000 | 0.56% |
| Orbimed Advisors | 13,621,443 | $39,502,000 | 0.38% |
| CARL DOMINO INC | 83,000 | $241,000 | 0.29% |
| KNOTT DAVID M | 158,400 | $459,000 | 0.20% |